Prevalence of Hepatitis C virus antibodies among different populations of relative and attributable risk

Saudi Medical Journal

Volumn 23, Issue 11, 2002, Pages 1356-1360

  Daw, Mohamed A ^a   Elkaber, Mohamed A ^a   Drah, Aisha M ^a   Werfalli, Mansour M ^a   Mihat, Abdulgadir A ^a   Siala, Ismail M ^a  

^a TRIPOLI CENTRAL HOSPITAL   (Libyan Arab Jamahiriya)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN; INTERFERON; RIBAVIRIN;

ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEALTH CARE POLICY; HEALTH PROGRAM; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL PERSONNEL; HUMAN; INFECTION CONTROL; INFECTION RISK; LIBYAN ARAB JAMAHIRIYA; MALE; MEDICAL EDUCATION; NORMAL HUMAN; PREVALENCE; PROSPECTIVE STUDY; REGISTER; STATISTICAL ANALYSIS;

FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; PROSPECTIVE STUDIES; SAUDI ARABIA; SEROEPIDEMIOLOGIC STUDIES;

EID: 0036872249     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Strickland GT. Hepatitis C in developing countries. Post Grad Doctor 2001; 16:375-378.
2. Farci P, Shimoda A, Coiana A. The outcome of acute hepatitis C predicted by the evolution of viral quasispecies. Science 2000; 288: 339-344.
3. Lechner F, Wong DK, Dunbar PR. Analysis of successful immune response in persons infected with hepatitis C virus. J Exp Med 2000; 191: 1499-1512.
4. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997; 25: 625-658.
5. Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the viral hepatitis prevention Board. Antwerp, Belgium. J Viral Hepat 1999; 6: 35-47
6. Armstrong GI, Alter MJ, McQuillan GM, Margolis HS. The past incidence of hepatitis C infection: implications for the future burden of chronic disease in the United States. Hepatology 2000; 31: 777-782.
7. Daw MA, Siala IM, Warfalli MM, Muftah MI. Seroepidemiology of hepatitis B virus markers among hospital health care workers; analysis of certain potential risk factors. Saudi Med J 2000; 21: 1157-1160.
8. Daw MA, Elzubidi IA, Ghenghesh KS, Piero S. Hepatitis B virus; pathogenesis and clinical aspects. Post Grad Doctor 1999; 22: 15-20.
9. Fletcher RH, Fletcher SW, Wagner EH. Relative and attributable risk factors. Clinical epidemiology; the essentials. Baltimore (MD): Williams & Wilkins; 1996. p. 94-110.
10. Abdel-Aziz F, Habib M, Mohammed MK. Hepatitis C virus infection in a community in the Nile delta: population description and HCV prevalence. Hepatology 2000; 32: 111-115.
11. Frank C, Mohammed MK, Strickland GT. The role of parentral antischistosomal therapy in spread of hepatitis C virus in Egypt. Lancet 2000; 355: 887-891.
12. Othman BM, Monem FS. Prevalence of hepatitis C virus antibodies among health care workers in Damascus, Syria. Saudi Med J 2001; 22: 603-605.
13. Mehdi S, Pophali A, Rahim KAA. Prevalence of hepatitis B and C among blood donors. Saudi Med J 2000; 21: 942-944.
14. Falasca E, Raphenon G, Pipan C, Diouf B, Seignot P, Botta G. Hepatitis C virus RNA (HCV RNA) and viral types in dialysis patients in Dakar, Senegal. Clin Microbiol Infect 1999; 5: 230-232.
15. Mayans RJ, Bustamante RC, Mondragon FZ, Rivera NM, Tello, Navarrete N. Hepatitis C virus antibodies in a Mexican population. Paed Infect Dis J 1998; 17: 169-170.
16. Khan AJ, Luby SP, Fikree F, Karim A, Obaid S, Dellawala S. Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan. Bull WHO 2000; 20: 956-963.
17. Galeazzi B, Tufano A, Barbierato E, Bortolotti E. Hepatitis C virus infection in Italian intravenous drug users: epidemiological and clinical aspects. Liver 1995: 15: 209-212.
18. Daw MA, Siala IM, Warfalli MM, Baccush M Elassabi H. Prevalence of HBsAg among Libyan populations; a comparative study. Annals of Saudi Medicine 2001; 21; 130-132.
19. Valcavi P, Natali A, Dieci E, Pilotti A, Chezzi C. Prevalence of hepatitis C irus antibodies in a clinic-based group of Italians from one geographic area. Clin Microbiol Infect 1999; 5: 125-129.
20. Tsai JF, Jeng JE, Ho MS, Chang WY, Lin ZY, Tsai JH. Independent and additive effect modification of hepatitis C and B virus infection on the development of chronic hepatitis. J Hepatol 1996: 24: 271-276.
21. Stroffolini T, Chiaramonte M, Tiribelli C. Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma; relative risk and population attributable risk from a case-control study in Italy. J Hepatol 1992; 16: 360-367.
22. Arya S. Hepatitis B virus among Libyan health care workers. Saudi Med J 2001; 22: 930-935.
23. Brouwer J, Hansen B, Niester H, Schalm S. Early prediction of response in interferon mono-therapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT. J Hepatol 1999; 30: 192-198.
24. Farrell G, Bacon B, Goldin R. The clinical advisory group for hepatitis C comparative study. Lymphoblastoid interferon alfa-n1 improves long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interfern alfa-2b: results of international randpmized controlled trials. Hepatology 1998; 27: 1121-1127.
25. Heathcote J. Antiviral therapy of patients with chronic hepatitis C. Sem Liver Disease 2000; 20: 185-199.
26. Jaeckel J. Treatment of acute hepatitis C with interferon Alfa 3b. N Engl J Med 2001; 345: 1452-1457.
27. Zeuzem S, Feinman V, Rasenack J, Heathcorte J, Lai M, Gane E et al. Peginterferon Alfa-2a in patient with chronic hepatitis C. N Engl J Med 2000; 343: 1666-1672.
28. Glue P. A does-ranging study of pegylated interferon alfa-2b and Ribavarin in chronic hepatitis C. The hepatitis C intervention therapy group. Hepatology 2000; 32: 647-653.
29. Daw MA, Ghenghesh KS, Elzubidi IA, Piero S. Hepatitis G virus: a true hepatotropic virus? Post Grad Doctor (Africa) 2001; 23: 80-85.
30. Osoba A. Hepatitis C virus genotypes in the Kingdom of Saudi Arabia. Saudi Med J 2002; 23: 7-12.